Sort   by:  
 Page size 
UnknownEpithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model.
Not available
S-EPMC8446762 | biostudies-literature
UnknownFeasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
Not available
S-EPMC6800044 | biostudies-literature
UnknownNicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
Not available
S-EPMC10449793 | biostudies-literature
UnknownGlobal transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.
Not available
S-EPMC4058362 | biostudies-literature
UnknownRecurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Not available
S-EPMC4970909 | biostudies-literature
UnknownPharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.
Not available
S-EPMC8171087 | biostudies-literature
UnknownAcetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
Not available
S-EPMC7969754 | biostudies-literature
UnknownThe Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.
Not available
S-EPMC9381093 | biostudies-literature
UnknownReappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
Not available
S-EPMC8015937 | biostudies-literature
UnknownInternational Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.
Not available
S-EPMC12754735 | biostudies-literature
Sort   by:  
 Page size